Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 105,149 | 77,964 | 43,458 | 25,086 | -3,603 |
| Depreciation Amortization | 304,684 | 194,933 | 96,111 | 439,435 | 332,976 |
| Income taxes - deferred | -132,211 | -99,560 | -25,829 | -135,553 | -128,427 |
| Accounts receivable | 11,497 | 19,132 | 1,335 | -76,529 | -39,048 |
| Other Working Capital | 84,156 | 55,656 | -7,928 | 258,714 | -113,322 |
| Other Operating Activity | 241,488 | 193,452 | 105,739 | 216,833 | 498,495 |
| Operating Cash Flow | $614,763 | $441,577 | $212,886 | $727,986 | $547,071 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 192,180 | 251,914 | -65,846 | -361,013 | -227,007 |
| Purchase Of Investment | -1,239,970 | -505,317 | -293,707 | -3,213,051 | -2,892,683 |
| Sale Of Investment | 1,536,475 | 1,276,382 | 354,839 | 3,200,386 | 2,937,055 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -8,750 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -8,750 | 0 |
| Investing Cash Flow | $488,685 | $1,022,979 | $-4,714 | $-382,428 | $-182,635 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -35,439 | -31,122 | -22,611 | 9,931 | -10,646 |
| Debt Repayment | -746,415 | -746,415 | N/A | N/A | N/A |
| Common Stock Issued | 88,041 | 64,433 | 49,910 | 273,535 | 208,768 |
| Common Stock Repurchased | -322,590 | -322,590 | -168,475 | -734,427 | -698,390 |
| Financing Cash Flow | $-1,016,403 | $-1,035,694 | $-141,176 | $-450,961 | $-500,268 |
| Exchange Rate Effect | N/A | 91 | N/A | N/A | N/A |
| Beginning Cash Position | 209,447 | 209,447 | 209,447 | 314,850 | 314,850 |
| End Cash Position | 296,492 | 638,400 | 276,443 | 209,447 | 179,018 |
| Net Cash Flow | $87,045 | $428,953 | $66,996 | $-105,403 | $-135,832 |
| Free Cash Flow | |||||
| Operating Cash Flow | 614,763 | 441,577 | 212,886 | 727,986 | 547,071 |
| Capital Expenditure | -215,950 | -156,216 | -65,846 | -361,013 | -227,007 |
| Free Cash Flow | 398,813 | 285,361 | 147,040 | 366,973 | 320,064 |